Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses. [electronic resource]
Producer: 20180221Description: 83987-84002 p. digitalISSN:- 1949-2553
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- genetics
- DNA Copy Number Variations
- Female
- Gene Dosage
- Gene Expression Profiling -- methods
- Gene Expression Regulation, Neoplastic
- Genetic Predisposition to Disease
- Humans
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Middle Aged
- Oligonucleotide Array Sequence Analysis
- Phenotype
- Predictive Value of Tests
- Prospective Studies
- Recurrence
- Risk Factors
- Time Factors
- Transcriptome
- Treatment Failure
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.